ArticleScientific reports2025
Effect of ultrasound-microbubble exposure on acute myeloid leukemia cancer cell proteome.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The application of ultrasound in combination with microbubbles (USMB) induces a broad spectrum of bioeffects on cells including plasma membrane disruption, cytoskeleton rearrangement, influx/efflux of cytosolic/extracellular molecules, metabolic stress and signalling pathways. This study investigated the effect of USMB on cell proteomics in human acute myeloid leukemia cells. Cells (OCI-AML-5) in suspension were exposed to ultrasound (f = 1 MHz, PD = 20 μs and PRP = 1 ms for 120 s) with and without microbubbles (Definity at 1.7% v/v) at varying acoustic pressures. Following exposure, cells were analysed using flow cytometry, mass spectrometry and immunoblotting. USMB enhanced cell membrane permeability (~ 37%), as expected, and induced significant changes in the cell proteome. Of 6825 proteins, 78 (~ 1.14%) were statistically significant and had a fold-change (≤ 0.8 or ≥ 1.2) compared to untreated control, referred to as a differentially expressed protein (DEP). The highest fold change of ~ 4-5 was induced in HMOX1 protein. The protein expression depended on acoustic pressure, presence of microbubbles and elapsed-time following exposure to ultrasound. Western blotting analysis confirmed the effect of USMB on three proteins (HMOX1, BACH1 and ANXA1) with R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.